Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (141-150 of 280) with videos related to

Pageof 28
Sort By:
International Journal of Cancer|September 22, 2018
Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunctionSubhayan Chattopadhyay, Amit Sud, Guoqiao Zheng, et al.
Plos One|June 25, 2015
Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumorsSiri Tähtinen, Saija Kaikkonen, Maiju Merisalo-Soikkeli, et al.
Plos One|October 8, 2010
Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5Marko T Ahonen, Iulia Diaconu, Sari Pesonen, et al.
Oncoimmunology|July 29, 2016
Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive settingMikko Siurala, Markus Vähä-Koskela, Riikka Havunen, et al.
Plos One|November 11, 2011
Optimized mouse model for the imaging of tumor metastasis upon experimental therapySergio Lavilla-Alonso, Usama Abo-Ramadan, Juha Halavaara, et al.
Human Gene Therapy|January 6, 2015
Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirusMari Hirvinen, Maria Rajecki, Mika Kapanen, et al.
Cells|April 30, 2021
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as CarriersJoao Santos, Camilla Heiniö, Dafne Quixabeira, et al.
Plos One|August 14, 2008
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenovirusesAnna Kanerva, Sergio Lavilla-Alonso, Mari Raki, et al.
Plos One|March 14, 2012
SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131IMaria Rajecki, Mirkka Sarparanta, Tanja Hakkarainen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous MelanomaSiri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
Pageof 28

Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|September 22, 2018
Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunctionSubhayan Chattopadhyay, Amit Sud, Guoqiao Zheng, et al.
Plos One|June 25, 2015
Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumorsSiri Tähtinen, Saija Kaikkonen, Maiju Merisalo-Soikkeli, et al.
Plos One|October 8, 2010
Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5Marko T Ahonen, Iulia Diaconu, Sari Pesonen, et al.
Oncoimmunology|July 29, 2016
Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive settingMikko Siurala, Markus Vähä-Koskela, Riikka Havunen, et al.
Plos One|November 11, 2011
Optimized mouse model for the imaging of tumor metastasis upon experimental therapySergio Lavilla-Alonso, Usama Abo-Ramadan, Juha Halavaara, et al.
Human Gene Therapy|January 6, 2015
Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirusMari Hirvinen, Maria Rajecki, Mika Kapanen, et al.
Cells|April 30, 2021
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as CarriersJoao Santos, Camilla Heiniö, Dafne Quixabeira, et al.
Plos One|August 14, 2008
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenovirusesAnna Kanerva, Sergio Lavilla-Alonso, Mari Raki, et al.
Plos One|March 14, 2012
SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131IMaria Rajecki, Mirkka Sarparanta, Tanja Hakkarainen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous MelanomaSiri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
Pageof 28